𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program

✍ Scribed by Matthew R Weir; Rhoda S Sperling; Alise Reicin; Barry J Gertz


Book ID
117008888
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
221 KB
Volume
146
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES